Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Mar 2;3(3):e201934.
doi: 10.1001/jamanetworkopen.2020.1934.

The Effect of Improving Basic Preventive Measures in the Perioperative Arena on Staphylococcus aureus Transmission and Surgical Site Infections: A Randomized Clinical Trial

Randy W Loftus  1 , Franklin Dexter  1 , Michael J Goodheart  1 , Megan McDonald  1 , John Keech  1 , Nicolas Noiseux  1 , Andrew Pugely  1 , William Sharp  1 , Mel Sharafuddin  1 , W Thomas Lawrence  1 , Mark Fisher  1 , Patrick McGonagill  1 , Jennifer Shanklin  1   2 , Dionne Skeete  1 , Chad Tracy  1 , Bradley Erickson  1 , Thomas Granchi  1 , Lance Evans  1 , Eli Schmidt  1 , Joshua Godding  1 , Raven Brenneke  1 , Deanna Persons  1 , Alexia Herber  1 , Mark Yeager  3 , Brent Hadder  1 , Jeremiah R Brown  4
Affiliations
Randomized Controlled Trial

The Effect of Improving Basic Preventive Measures in the Perioperative Arena on Staphylococcus aureus Transmission and Surgical Site Infections: A Randomized Clinical Trial

Randy W Loftus et al. JAMA Netw Open. .

Abstract

Importance: Surgical site infections increase patient morbidity and health care costs. The Centers for Disease Control and Prevention emphasize improved basic preventive measures to reduce bacterial transmission and infections among patients undergoing surgery.

Objective: To assess whether improved basic preventive measures can reduce perioperative Staphylococcus aureus transmission and surgical site infections.

Design, setting, and participants: This randomized clinical trial was conducted from September 20, 2018, to September 20, 2019, among 19 surgeons and their 236 associated patients at a major academic medical center with a 60-day follow-up period. Participants were a random sample of adult patients undergoing orthopedic total joint, orthopedic spine, oncologic gynecological, thoracic, general, colorectal, open vascular, plastic, or open urological surgery requiring general or regional anesthesia. Surgeons and their associated patients were randomized 1:1 via a random number generator to treatment group or to usual care. Observers were masked to patient groupings during assessment of outcome measures.

Interventions: Sustained improvements in perioperative hand hygiene, vascular care, environmental cleaning, and patient decolonization efforts.

Main outcomes and measures: Perioperative S aureus transmission assessed by the number of isolates transmitted and the incidence of transmission among patient care units (primary) and the incidence of surgical site infections (secondary).

Results: Of 236 patients (156 [66.1%] women; mean [SD] age, 57 [15] years), 106 (44.9%) and 130 (55.1%) were allocated to the treatment and control groups, respectively, received the intended treatment, and were analyzed for the primary outcome. Compared with the control group, the treatment group had a reduced mean (SD) number of transmitted perioperative S aureus isolates (1.25 [2.11] vs 0.47 [1.13]; P = .002). Treatment reduced the incidence of S aureus transmission (incidence risk ratio; 0.56; 95% CI, 0.37-0.86; P = .008; with robust variance clustering by surgeon: 95% CI, 0.42-0.76; P < .001). Overall, 11 patients (4.7%) experienced surgical site infections, 10 (7.7%) in the control group and 1 (0.9%) in the treatment group. Transmission was associated with an increased risk of surgical site infection (8 of 73 patients [11.0%] with transmission vs 3 of 163 [1.8%] without; risk ratio, 5.95; 95% CI, 1.62-21.86; P = .007). Treatment reduced the risk of surgical site infection (hazard ratio, 0.12; 95% CI, 0.02-0.92; P = .04; with clustering by surgeon: 95% CI, 0.03-0.51; P = .004).

Conclusions and relevance: Improved basic preventive measures in the perioperative arena can reduce S aureus transmission and surgical site infections.

Trial registration: ClinicalTrials.gov Identifier: NCT03638947.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Patient Enrollment Schematic
Figure 2.
Figure 2.
Effect of the multifaceted approach on perioperative staphylococcus aureus reservoir transmission.
Figure 3.
Figure 3.
Effect of the multifaceted program on surgical site infections
See this image and copyright information in PMC

Comment in

References

    1. Magill SS, O’Leary E, Janelle SJ et al. ; Emerging Infections Program Hospital Prevalence Survey Team. Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals. N Engl J Med 2018; 379:1732–1744. - PMC - PubMed
    1. Magill SS, Hellinger W, Cohen J, et al. Prevalence of healthcare-associated infections in acute care hospitals in Jacksonville, Florida. Infect Control Hosp Epidemiol 2012; 33: 283–91. - PMC - PubMed
    1. Boucher HW, Talbot GH, Bradley JS, et al. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America. Clinical Infectious Diseases 2009; 48:1–12. - PubMed
    1. Vogel TR, Dombrovskiy VY, Lowry SF. Impact of Infectious Complications after Elective Surgery on Hospital Re-Admission and late Deaths in the U.S. Medicare Population. Surg Infect (Larchmt) 2012; 13: 307–1. - PubMed
    1. Awad SS, “Adherence to surgical care improvement project measures and postoperative surgical site infections”. Surgical Infection (Larchmt) 2012, 13: 234–7. - PubMed

Publication types

Associated data